aspirin has been researched along with Thrombophlebitis in 268 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Thrombophlebitis: Inflammation of a vein associated with a blood clot (THROMBUS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among the patients with hip fracture, allocation to aspirin produced proportional reductions in pulmonary embolism of 43% (95% CI 18-60; p=0." | 9.09 | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. ( , 2000) |
| "Inogatran (MW 439 Da), a new, selective, active site inhibitor of thrombin, was evaluated in three rat models of thrombosis." | 7.69 | Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time. ( Börjesson, I; Elg, M; Gustafsson, D; Lenfors, S; Teger-Nilsson, AC, 1996) |
| "The efficacy of two antithrombotic regimens, combined dextran and aspirin and combined dextran and warfarin, was analyzed by comparing the incidence of thromboembolism following total hip replacement in two groups of similar patients." | 7.65 | Thromboembolism following total hip-replacement arthroplasty. The efficicy of dextran-aspirin and dextran-warfarin in prophylaxis. ( Lachiewicz, P; Salvati, EA, 1976) |
| "Thrombus was formed within seconds after laser injury and grew rapidly." | 5.29 | Antithrombotic effects of aspirin and LMWH in a laser-induced model of arterials and venous thrombosis. ( Aguejouf, O; Doutremepuich, C; Doutremepuich, F; Imbault, P, 1996) |
| "Aspirin (650 mg) was given the night prior to surgery and continued at that dose twice per day." | 5.28 | Aspirin prophylaxis and surveillance of pulmonary embolism and deep vein thrombosis in total hip arthroplasty. ( Jones, K; Lachiewicz, PF; McCardel, BR, 1990) |
| "Among the patients with hip fracture, allocation to aspirin produced proportional reductions in pulmonary embolism of 43% (95% CI 18-60; p=0." | 5.09 | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. ( , 2000) |
| " The recent clinical reports suggest that there is a narrower window of safety with recombinant hirudin than initially thought particularly when it is used in conjunction with thrombolytic agents and aspirin in acute myocardial infarction." | 4.79 | Advances in antithrombotic therapy: novel agents. ( Hirsh, J; Turpie, AG; Weitz, JI, 1995) |
| "Inogatran (MW 439 Da), a new, selective, active site inhibitor of thrombin, was evaluated in three rat models of thrombosis." | 3.69 | Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time. ( Börjesson, I; Elg, M; Gustafsson, D; Lenfors, S; Teger-Nilsson, AC, 1996) |
| " Of the fifty-eight patients who had received aspirin throughout their course in the hospital, two (3 per cent) had severe ectopic ossification (grade III or IV8)." | 3.68 | Effect of aspirin on heterotopic ossification after total hip arthroplasty in men who have osteoarthrosis. ( Pagnani, MJ; Pellicci, PM; Salvati, EA, 1991) |
| "Two highly sensitive models of arterial and venous thrombosis forming with the test of endothelial stability a complementary system with a maximum stress on the role of vascular lesion were used to test a series of four antithrombotic drugs (heparin, acetylsalicylic acid, dipyridamole, sulfinpyrazone) and four drugs with other indications but with an antithrombotic activity in experiment (prenylamine, troxerutin, ketanserin and pizotifen)." | 3.67 | Antithrombotics in view of thrombosis models. ( Hladovec, J, 1986) |
| " In nine patients who took aspirin regularly the incidence of thromboembolism was 11 per cent, while in the eight who did not take aspirin or any other antiplatelet drug the incidence was 88 per cent, a difference which was highly significant (p = 0." | 3.65 | Thromboembolic disease in patients undergoing total knee replacement. ( Bachmann, F; Galante, JO; Kaushal, SP; McKenna, R, 1976) |
| "The efficacy of two antithrombotic regimens, combined dextran and aspirin and combined dextran and warfarin, was analyzed by comparing the incidence of thromboembolism following total hip replacement in two groups of similar patients." | 3.65 | Thromboembolism following total hip-replacement arthroplasty. The efficicy of dextran-aspirin and dextran-warfarin in prophylaxis. ( Lachiewicz, P; Salvati, EA, 1976) |
| " In the presence of thrombophlebitis, phenylbutazone (Butazolidin) is used." | 3.65 | A multifaceted approach to prevention of thromboembolism: a report of 529 cases. ( Brady, LP, 1977) |
| "Aspirin was used as prophylaxis against thromboembolism during the first half of the study and adjusted-dose warfarin during the second half." | 2.68 | The frequency of venous thrombosis in cemented and non-cemented hip arthroplasty. ( Bourne, R; Bullas, R; Feeny, D; Laupacis, A; Rankin, R; Rorabeck, C; Tugwell, P; Vellet, AD; Wong, C, 1996) |
| "The incidence of pulmonary embolism on lung scan was 12% with epidural anesthesia and 9% with general anesthesia." | 2.68 | Randomized trial of epidural versus general anesthesia: outcomes after primary total knee replacement. ( Ganz, SB; Go, G; Haas, SB; Insall, J; Laskin, RS; Ranawat, CS; Sharrock, NE; Williams-Russo, P; Windsor, RE, 1996) |
| " The risk factors affecting the incidence of the venous thrombosis are confirmed to be obesity and long-term administration of steroids." | 2.68 | Deep vein thrombosis after uncemented total hip replacement. ( Cho, JL; Choi, IY; Kim, YH; Park, MR; Park, TS, 1997) |
| "Proximal vein thrombosis or pulmonary embolism occurred in 6 patients (9." | 2.66 | A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. ( Gent, M; Hirsh, J; Jay, RM; Julian, DH; Levine, M; Powers, PJ; Turpie, AG, 1989) |
| ") combined with aspirin." | 2.64 | Comparision of low dose heparin and low dose heparin combined with aspirin in prevention of deep vein thrombosis after total hip replacement. ( Blery, M; Flicoteaux, H; Honnart, F; Jean, N; Judet, T; Kher, A; Pasteyer, J, 1977) |
| " Increasing the heparin dosage postoperatively to 3 X 7500 IU/24 h effectively prevented the incidence of thrombosis by reducing it to 11% in these high-risk patients." | 2.64 | [Heparin in the prevention of thromboembolism after elective hip-joint operations (author's transl)]. ( Schöndorf, TH, 1978) |
| "The frequency in letal pulmonary embolism at the I." | 2.64 | [Thrombosis, embolism and aggregation inhibitors in surgery]. ( Zekert, F, 1976) |
| "Treatment with aspirin reduced urinary excretion of 5-hydroxy indole acetic acid--presumably by inhibiting in vivo platelet release of serotonin, reduced postoperative consumption of platelets, and reduced the mean corpuscular volume of the platelet population." | 2.64 | The influence of aspirin on postoperative platelet kinetics and venous thrombosis. ( Clagett, GP; Rosoff, CB; Salzman, EW; Schneider, P, 1975) |
| "Because the risk of recurrence is high, the standard of care is prolonged and high-intensity warfarin (INR near 3) after a venous thromboembolic event, together with the management of associated vascular risk factors." | 2.41 | [Antiphospholipid syndrome]. ( Arvieux, J; Hachulla, E, 2002) |
| "Triflusal is an antiplatelet agent structurally related to the salicylate group of compounds, but it is not derived from aspirin (acetylsalicylic acid)." | 2.40 | Triflusal. ( Goa, KL; McNeely, W, 1998) |
| "Aspirin has been disappointing." | 2.38 | Deep venous thrombosis and pulmonary emboli: etiology, medical treatment, and prophylaxis. ( Coffman, JD, 1989) |
| "Dipyridamole can inhibit both platelet adhesion and aggregation by raising the platelet cyclic AMP level through phosphodiesterase inhibition." | 2.37 | Aspirin and other platelet-aggregation inhibiting drugs. ( Gallus, AS, 1985) |
| "Thrombus was formed within seconds after laser injury and grew rapidly." | 1.29 | Antithrombotic effects of aspirin and LMWH in a laser-induced model of arterials and venous thrombosis. ( Aguejouf, O; Doutremepuich, C; Doutremepuich, F; Imbault, P, 1996) |
| "The risk of death from pulmonary embolism was similarly diminished in the group that received warfarin." | 1.28 | Venous thromboembolism associated with hip and knee arthroplasty: current prophylactic practices and outcomes. ( Heit, JA; Ilstrup, DM; Mohr, DN; Morrey, BF; Silverstein, MD, 1992) |
| "Aspirin (650 mg) was given the night prior to surgery and continued at that dose twice per day." | 1.28 | Aspirin prophylaxis and surveillance of pulmonary embolism and deep vein thrombosis in total hip arthroplasty. ( Jones, K; Lachiewicz, PF; McCardel, BR, 1990) |
| "In the presence of a chronic consumption coagulopathy, it remains uncertain whether antiplatelet drugs are of prophylactic antithrombotic value." | 1.28 | Blue rubber-bleb naevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis. ( Bouquet, J; Hofhuis, WJ; Oranje, AP; Sinaasappel, M, 1990) |
| "A clinical diagnosis of systemic lupus erythematosus (SLE) was made in four women." | 1.27 | Lupus anticoagulant in pregnancy. ( Butler, WS; Liggins, GC; Lubbe, WF; Palmer, SJ, 1984) |
| " A prevention of thromboembolic disease by individual dosage of heparin must be considered in patients at high risk for thromboembolic disease." | 1.27 | [Mortality and morbidity of thromboembolism in drug prevention--5-year analysis]. ( Hopp, A; Hopp, H; Knispel, J, 1988) |
| " Laboratory determinations were used to directly evaluate therapeutic anticoagulant effects, and dosage regimens were adjusted to achieve desired anticoagulant levels." | 1.26 | Case study: complications associated with anticoagulant therapy. ( Davis, GL; Mutnick, AH, 1981) |
| " It appears from this study that in these cases prophylaxis against venous thromboembolism using aspirin in a dosage of 600 mg bid is ineffective." | 1.26 | Aspirin prophylaxis of venous thromboembolic disease following fracture of the upper femur. ( Channon, GM; Wiley, AM, 1979) |
| "Sulfinpyrazone treatment of patients with myocardial infarction (Killip--classification I and II), starting 25--35 days after the acute myocardial infarction, reduces cardiac mortality and incidence of sudden death for a period of two years." | 1.26 | [Action mechanism and clinical indications for thrombocyte aggregation inhibitors]. ( Oelz, O, 1979) |
| " No results with Colfarit were noted in the branch vein thromboses, in fact bleeding recurred in almost every case in the fifth week, when Colfarit was given for longer than 4 weeks in the dosage of 3 times 0." | 1.26 | [Observations and results of photodocumentation of retinal thromboses treated with Colfarit (author's transl)]. ( Schlosshardt, H, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 204 (76.12) | 18.7374 |
| 1990's | 53 (19.78) | 18.2507 |
| 2000's | 10 (3.73) | 29.6817 |
| 2010's | 1 (0.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kahn, JE | 1 |
| Veyssier-Belot, C | 1 |
| Renier, JL | 1 |
| de Mazancourt, P | 1 |
| Peltier, JY | 1 |
| de Raucourt, E | 1 |
| Turpie, AG | 7 |
| Vilela, VS | 1 |
| de Jesús, NR | 1 |
| Levy, RA | 1 |
| Arvieux, J | 1 |
| Hachulla, E | 1 |
| Magy, N | 1 |
| Gil, H | 1 |
| Racadot, E | 1 |
| Dupond, JL | 1 |
| Braun, S | 1 |
| Jünger, M | 1 |
| Bruhn, HD | 1 |
| Sowier, J | 2 |
| Zawilska, K | 1 |
| Wencel, D | 1 |
| Chojnacki, J | 1 |
| Jaroszewicz, S | 1 |
| Genton, E | 4 |
| Foegh, ML | 1 |
| Winchester, JF | 1 |
| Zmudka, M | 1 |
| Helfrich, GB | 1 |
| Ramwell, PW | 1 |
| Schreiner, GE | 1 |
| Lubbe, WF | 2 |
| Butler, WS | 2 |
| Palmer, SJ | 2 |
| Liggins, GC | 2 |
| Borow, M | 2 |
| Goldson, H | 1 |
| Lowe, LW | 1 |
| Westermann, K | 1 |
| Trentz, O | 1 |
| Pretschner, P | 1 |
| Mellmann, J | 1 |
| Kugelmeier, J | 1 |
| Egloff, L | 1 |
| Hetherington, V | 1 |
| Petrantoni, C | 1 |
| Pilla, P | 1 |
| Kakkar, VV | 7 |
| Zielinsky, A | 1 |
| Hirsh, J | 12 |
| de Boer, AC | 1 |
| Russell, JC | 1 |
| Goldson, HJ | 1 |
| Vara-Thorbeck, R | 2 |
| Morales, OI | 1 |
| Bazzan, M | 1 |
| Pannocchia, A | 1 |
| Schinco, PC | 1 |
| Della Dora, N | 1 |
| Tamponi, G | 1 |
| Sautter, RD | 2 |
| Koch, EL | 1 |
| Myers, WO | 1 |
| Ray, JR | 1 |
| Mazza, JJ | 1 |
| Larson, DE | 1 |
| Chen, HM | 1 |
| Milbauer, JP | 1 |
| Treuhaft, PS | 1 |
| Plotka, ED | 1 |
| Marcus, AJ | 2 |
| Fitzpatrick, JW | 1 |
| Giudice, JC | 1 |
| Papa, L | 1 |
| Freed, N | 1 |
| Ordinas, A | 1 |
| Alho, A | 1 |
| Stangeland, L | 1 |
| Røttingen, J | 1 |
| Wiig, JN | 1 |
| Bouchier-Hayes, D | 1 |
| Klotz, TA | 1 |
| Cohn, LS | 1 |
| Zipser, RD | 1 |
| Kalkowski, H | 1 |
| Rinke, W | 1 |
| Dohse, D | 1 |
| Herzog, S | 1 |
| Verstraete, M | 6 |
| Salzman, EW | 9 |
| Davies, GC | 1 |
| Green, D | 1 |
| Rossi, EC | 1 |
| Yao, JS | 1 |
| Flinn, WR | 1 |
| Spies, SM | 1 |
| McKenna, R | 2 |
| Galante, J | 1 |
| Bachmann, F | 2 |
| Wallace, DL | 1 |
| Kaushal, PS | 1 |
| Meredith, P | 1 |
| Covey, TH | 1 |
| Baue, AE | 1 |
| Weiss, HJ | 3 |
| Sloan, RW | 1 |
| Warlow, CP | 1 |
| Schöndorf, TH | 6 |
| Broomé, A | 1 |
| Davidsson, T | 1 |
| Eklöf, B | 1 |
| Hansson, L | 1 |
| Davis, GL | 1 |
| Mutnick, AH | 1 |
| Baluda, VP | 2 |
| Lakin, KM | 1 |
| Pabvlishchuk, SA | 1 |
| Deianov, I | 2 |
| Nedelkovskiĭ, I | 1 |
| DeLee, JC | 1 |
| Rockwood, CA | 1 |
| Reyers, I | 1 |
| Mussoni, L | 1 |
| Donati, MB | 1 |
| de Gaetano, G | 1 |
| RuDusky, BM | 1 |
| Croveri, G | 1 |
| Li, X | 1 |
| Cooley, BC | 1 |
| Labaye, A | 1 |
| Nores, JM | 1 |
| Bergal, S | 1 |
| Denormandie, P | 1 |
| Nozdrachev, IuI | 1 |
| Oswald, M | 1 |
| Beuers, U | 1 |
| Pape, GR | 1 |
| Paumgartner, G | 1 |
| Monreal, M | 1 |
| Lafoz, E | 1 |
| Roca, J | 1 |
| Granero, X | 1 |
| Soler, J | 1 |
| Salazar, X | 1 |
| Olazabal, A | 1 |
| Bergqvist, D | 2 |
| Feldman, DS | 1 |
| Zuckerman, JD | 1 |
| Walters, I | 1 |
| Sakales, SR | 1 |
| Han, G | 1 |
| Bond, SE | 1 |
| Lawrence, WH | 1 |
| Dillingham, EO | 1 |
| Zheng, X | 1 |
| Gollamudi, R | 1 |
| Grady-Benson, JC | 1 |
| Oishi, CS | 1 |
| Hanson, PB | 1 |
| Colwell, CW | 1 |
| Otis, SM | 1 |
| Walker, RH | 1 |
| Fredrich, M | 1 |
| Zierz, R | 1 |
| Morser, J | 1 |
| Wydro, R | 1 |
| Witt, W | 1 |
| Bernat, A | 2 |
| Herbert, JM | 1 |
| Rodgers, A | 2 |
| Gray, H | 1 |
| MacMahon, S | 2 |
| Lieberman, JR | 1 |
| Huo, MM | 1 |
| Hanway, J | 1 |
| Salvati, EA | 5 |
| Sculco, TP | 2 |
| Sharrock, NE | 2 |
| Kahle, B | 1 |
| Loeliger, EA | 1 |
| Wehmeier, A | 1 |
| Grossman, RS | 1 |
| Altman, R | 1 |
| Rouvier, J | 1 |
| Gurfinkel, E | 1 |
| Weitz, JI | 1 |
| Van Horn, G | 1 |
| Arnett, FC | 1 |
| Dimachkie, MM | 1 |
| Westrich, GH | 1 |
| Laupacis, A | 1 |
| Rorabeck, C | 1 |
| Bourne, R | 1 |
| Tugwell, P | 1 |
| Bullas, R | 1 |
| Rankin, R | 1 |
| Vellet, AD | 1 |
| Feeny, D | 1 |
| Wong, C | 1 |
| Labas, P | 1 |
| Vrtík, L | 1 |
| Svec, R | 1 |
| Sasváry, F | 1 |
| Imbault, P | 1 |
| Doutremepuich, F | 1 |
| Aguejouf, O | 1 |
| Doutremepuich, C | 1 |
| Gustafsson, D | 1 |
| Elg, M | 1 |
| Lenfors, S | 1 |
| Börjesson, I | 1 |
| Teger-Nilsson, AC | 1 |
| Williams-Russo, P | 1 |
| Haas, SB | 2 |
| Insall, J | 1 |
| Windsor, RE | 2 |
| Laskin, RS | 1 |
| Ranawat, CS | 1 |
| Go, G | 1 |
| Ganz, SB | 1 |
| Nettleman, MD | 1 |
| Alsip, J | 1 |
| Schrader, M | 1 |
| Schulte, M | 1 |
| Ridker, PM | 1 |
| Cushman, M | 1 |
| Stampfer, MJ | 1 |
| Tracy, RP | 1 |
| Hennekens, CH | 1 |
| Abdool-Carrim, T | 1 |
| Adler, H | 1 |
| Becker, P | 1 |
| Carides, M | 1 |
| Ginsberg, J | 1 |
| Golele, R | 1 |
| Grobler, G | 1 |
| Immelman, E | 1 |
| Louwrens, H | 1 |
| Lukhele, M | 1 |
| Veller, M | 1 |
| Watt, K | 1 |
| Weber, F | 1 |
| Williams, E | 1 |
| Kim, YH | 1 |
| Choi, IY | 1 |
| Park, MR | 1 |
| Park, TS | 1 |
| Cho, JL | 1 |
| Prentice, CR | 3 |
| Katano, K | 1 |
| Aoki, K | 1 |
| Ogasawara, M | 1 |
| Aoyama, T | 1 |
| Suzumori, K | 1 |
| McNeely, W | 1 |
| Goa, KL | 1 |
| Sors, H | 1 |
| Meyer, G | 1 |
| Collin, J | 1 |
| Fletcher, AP | 1 |
| Alkjaersig, NK | 1 |
| O'Brien, JR | 4 |
| Tulevski, V | 1 |
| Hume, M | 2 |
| Bierbaum, B | 1 |
| Kuriakose, TX | 1 |
| Surprenant, J | 1 |
| Harris, WH | 7 |
| Athanasoulis, CA | 2 |
| Waltman, AC | 4 |
| DeSanctis, RW | 4 |
| Flicoteaux, H | 1 |
| Kher, A | 1 |
| Jean, N | 1 |
| Blery, M | 1 |
| Judet, T | 1 |
| Honnart, F | 1 |
| Pasteyer, J | 1 |
| Donaldson, WR | 1 |
| Suprenant, J | 1 |
| Yasunaga, K | 1 |
| Sasahara, AA | 1 |
| Sharma, GV | 1 |
| Parisi, AF | 1 |
| Uhl, JF | 1 |
| Huguier, M | 1 |
| Scholz, PM | 1 |
| Jones, RH | 1 |
| Sabiston, DC | 1 |
| Oelz, O | 1 |
| Channon, GM | 1 |
| Wiley, AM | 1 |
| Hull, R | 1 |
| Delmore, TJ | 1 |
| Gent, M | 3 |
| Armstrong, P | 1 |
| Lofthouse, R | 1 |
| MacMillan, A | 1 |
| Blackstone, I | 1 |
| Reed-Davis, R | 1 |
| Detwiler, RC | 1 |
| Ts'ao, CH | 1 |
| Ali, N | 1 |
| Kolb, T | 1 |
| Zekert, F | 3 |
| Maffei, FH | 1 |
| Pinto, AM | 1 |
| Fabris, VE | 1 |
| Lastória, S | 1 |
| Rollo, HD | 1 |
| Loew, D | 3 |
| Adolf, J | 1 |
| Buttermann, G | 2 |
| Weidenbach, A | 2 |
| Gmeineder, F | 1 |
| Stamatakis, JD | 1 |
| Lawrence, D | 1 |
| Bentley, PG | 1 |
| Nairn, D | 1 |
| Ward, V | 1 |
| Yett, HS | 1 |
| Skillman, JJ | 2 |
| Hey, D | 4 |
| Schlosshardt, H | 1 |
| Lasch, HG | 2 |
| Ricotta, JJ | 1 |
| Collins, GJ | 1 |
| Rich, NM | 1 |
| Deykin, D | 1 |
| Bucher, HJ | 1 |
| Renney, JT | 2 |
| O'Sullivan, EF | 3 |
| Burke, PF | 1 |
| Breddin, K | 5 |
| Scharrer, I | 4 |
| Gavrilov, OK | 1 |
| Rachinskaia, NA | 1 |
| Kaveshnikova, BF | 1 |
| Gallus, AS | 3 |
| Roba, J | 1 |
| Claeys, M | 1 |
| Lambelin, G | 1 |
| Morris, GK | 1 |
| Mitchell, JR | 1 |
| Brady, LP | 1 |
| Stillman, RM | 1 |
| Chapa, L | 1 |
| Stark, ML | 1 |
| Malik, LN | 1 |
| Keates, JR | 1 |
| Sawyer, PN | 1 |
| Strandness, DE | 1 |
| Ward, K | 1 |
| Krugmire, R | 1 |
| Weber, U | 1 |
| Theisinger, W | 1 |
| Hartung, R | 1 |
| Welzel, D | 1 |
| Pabst, HW | 1 |
| Elwood, PC | 1 |
| Lachiewicz, P | 1 |
| Jennings, JJ | 1 |
| Sarmiento, A | 1 |
| Kaushal, SP | 1 |
| Galante, JO | 1 |
| Klement, AA | 1 |
| Khanina, TM | 1 |
| Kotovshchikova, MA | 1 |
| Osipov, SN | 1 |
| Lavrinovitsch, TS | 1 |
| Petuchova, LI | 1 |
| Slutskii, LI | 1 |
| Vinazzer, H | 2 |
| Joffe, SN | 1 |
| Arfors, KE | 1 |
| Tangen, O | 1 |
| Soreff, J | 1 |
| Johnsson, H | 1 |
| Diener, L | 1 |
| Göransson, L | 1 |
| Harker, LA | 3 |
| McBride, JA | 1 |
| Kraus, V | 1 |
| Hilz, C | 1 |
| Clagett, GP | 3 |
| Schneider, P | 1 |
| Rosoff, CB | 1 |
| Siefer, H | 1 |
| Hach, W | 1 |
| Ries, CA | 1 |
| Wu, KK | 2 |
| Barnes, RW | 1 |
| Hoak, JC | 1 |
| Paiement, GD | 1 |
| Schutzer, SF | 1 |
| Wessinger, SJ | 1 |
| Giedrojc, J | 1 |
| Fellier, H | 1 |
| Breddin, HK | 1 |
| Anderson, FA | 1 |
| Levine, MN | 1 |
| Wheeler, HB | 1 |
| Ginsberg, JS | 1 |
| Mohr, DN | 1 |
| Silverstein, MD | 1 |
| Ilstrup, DM | 1 |
| Heit, JA | 1 |
| Morrey, BF | 1 |
| Hach-Wunderle, V | 1 |
| Sola, JE | 1 |
| Stone, MM | 1 |
| Wise, B | 1 |
| Colombani, PM | 1 |
| Cohen, MG | 1 |
| Lui, SF | 1 |
| Mohr, VD | 1 |
| Lenz, J | 1 |
| Genyk, SN | 1 |
| Orishchak, DT | 1 |
| Rapold, HJ | 1 |
| Lu, HR | 1 |
| Wu, ZM | 1 |
| Nijs, H | 1 |
| Collen, D | 1 |
| Pagnani, MJ | 1 |
| Pellicci, PM | 1 |
| Trubuhovich, RV | 1 |
| Woolson, ST | 1 |
| Watt, JM | 1 |
| Ernst, E | 1 |
| McCardel, BR | 1 |
| Lachiewicz, PF | 1 |
| Jones, K | 1 |
| Hofhuis, WJ | 1 |
| Oranje, AP | 1 |
| Bouquet, J | 1 |
| Sinaasappel, M | 1 |
| Hladovec, J | 3 |
| Kornalík, F | 1 |
| Insall, JN | 1 |
| Scuderi, GR | 1 |
| Ghelman, B | 1 |
| Hull, RD | 1 |
| Raskob, GE | 1 |
| Lukoianova, TI | 1 |
| Rosell-Pradas, J | 1 |
| Coffman, JD | 1 |
| Pini, M | 1 |
| Spadini, E | 1 |
| Carluccio, L | 1 |
| Giovanardi, C | 1 |
| Magnani, E | 1 |
| Ugolotti, U | 1 |
| Uggeri, E | 1 |
| Powers, PJ | 1 |
| Jay, RM | 1 |
| Julian, DH | 1 |
| Levine, M | 1 |
| Livio, M | 1 |
| Benigni, A | 1 |
| Viganò, G | 1 |
| Mecca, G | 1 |
| Remuzzi, G | 1 |
| Tomai, F | 1 |
| Gioffrè, PA | 1 |
| Pieri, S | 1 |
| Palange, MA | 1 |
| Valci, F | 1 |
| Zanasi, R | 1 |
| Fioretta, G | 1 |
| Ciocia, G | 1 |
| Bergonzi, M | 1 |
| Rocha, E | 2 |
| Alfaro, MJ | 2 |
| Páramo, JA | 2 |
| Cañadell, JM | 1 |
| Hopp, H | 1 |
| Hopp, A | 1 |
| Knispel, J | 1 |
| Nicolas, G | 1 |
| Millet, J | 1 |
| Theveniaux, J | 1 |
| Pascal, M | 1 |
| Weiner, CP | 1 |
| Vallée, E | 1 |
| Maffrand, JP | 1 |
| Roncucci, R | 1 |
| Mocchi, N | 1 |
| Sbalzarini, G | 1 |
| Cantaluppi, P | 1 |
| Michal, M | 1 |
| Giessinger, N | 1 |
| Thomas, DP | 1 |
| Vreeken, J | 1 |
| van Aken, WG | 1 |
| Mayrhofer, EF | 1 |
| Kingdon, HS | 1 |
| DeWolfe, VG | 1 |
| Pisch, W | 1 |
| Hennes, H | 1 |
| Meng, K | 1 |
| O'Dea, K | 1 |
| Aglietti, P | 1 |
| Mendes, DG | 1 |
| Wilson, PD | 1 |
| Lazansky, MG | 1 |
| Hampton, J | 1 |
| Athanasoulis, C | 2 |
| Baum, S | 1 |
| Mintz, U | 1 |
| Bar-Meir, S | 1 |
| De Vries, A | 1 |
| Huntsman, RG | 1 |
| Lehmann, H | 1 |
| Vellar, ID | 1 |
| Lyon, LJ | 1 |
| Nevins, MA | 1 |
| Mandel, SR | 1 |
| Johnson, G | 1 |
| Edwards, IR | 1 |
| Walker, AE | 1 |
| Bouvier, CA | 1 |
| Duckert, F | 1 |
| Didisheim, P | 1 |
| Kazmier, FJ | 1 |
| Fuster, V | 1 |
| Forbes, CD | 1 |
| Sidhu, AK | 1 |
| Bhakoo, ON | 1 |
| Jolly, JG | 1 |
| Walia, BN | 1 |
| van der Molen, HR | 1 |
| Töth, LM | 1 |
| Graudins, J | 1 |
| Popp, G | 1 |
| Düben, W | 1 |
| Huch, FL | 1 |
| Gottlob, R | 1 |
| Sara, SM | 1 |
| Galambos, J | 1 |
| Bounameaux, Y | 1 |
| Wood, EH | 1 |
| McGrouther, DA | 1 |
| Sinclair, J | 1 |
| McNicol, GP | 1 |
| Zimmermann, R | 1 |
| Barth, P | 1 |
| Lindner, R | 1 |
| Heinrich, D | 1 |
| Burkhardt, H | 1 |
| Zelenock, GB | 1 |
| Stanley, JC | 1 |
| Lindenauer, SM | 1 |
| Fry, WJ | 1 |
| Wellmer, HK | 1 |
| Baer, U | 1 |
| Merguet, H | 1 |
| Rumpf, P | 1 |
| Petersen, H | 1 |
| Bromig, G | 1 |
| Persch, WF | 1 |
| Marx, FJ | 1 |
| von Bary, SM | 1 |
| Slichter, SJ | 1 |
| Seligman, B | 1 |
| Naess, K | 1 |
| Bollinger, A | 1 |
| Gemperli, M | 1 |
| Elcock, HW | 1 |
| Fredrickson, JM | 1 |
| Nahun, LH | 1 |
| Schepping, M | 1 |
| Stormorken, H | 1 |
| Sherry, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)[NCT03152058] | Phase 2 | 55 participants (Anticipated) | Interventional | 2017-05-17 | Recruiting | ||
| A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients[NCT02774265] | Phase 3 | 329 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
| The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery[NCT02684851] | Phase 3 | 87 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
| Pain Treatment After Total Knee Replacement - Continuous Epidural Versus Intravenous Patient Controlled Analgesia With Morphine[NCT00270322] | Phase 4 | 80 participants | Interventional | 2006-01-31 | Terminated (stopped due to We believe regional anesth better for TKR,90% patients got epidural. Last year we started spinal morphine one shot, and found it very promissing.) | ||
| [NCT00000500] | Phase 3 | 0 participants | Interventional | 1981-09-30 | Completed | ||
| Gender-Specific Effects of Physiologic GH Administration on Cardiovascular Risk Factors in Women With Growth Hormone Deficiency[NCT00136032] | 63 participants (Actual) | Interventional | 2002-01-31 | Completed | |||
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation in High Risk Primary Prevention (Patients With Metabolic Syndrome)[NCT00272311] | Phase 4 | 70 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| A Randomized Trial of Plaque Identifying Toothpaste on Reduction of Plaque and Inflammation[NCT02666508] | 61 participants (Actual) | Interventional | 2015-09-01 | Completed | |||
| Correlation Between Oral Health and Systemic Inflammation (COHESION)[NCT03641989] | 112 participants (Actual) | Interventional | 2018-09-17 | Completed | |||
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation & Endothelial Function in Secondary Prevention (Pts w/Chronic Stable Coronary Disease)[NCT00272337] | Phase 4 | 37 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
DVT and how the diagnosis was made will be recorded. The number of events in participants in each arm will be compared to evaluate efficacy. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 5 |
| VTE Prophylaxis With Aspirin 81mg BID | 9 |
Bases on imaging obtained for symptoms. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 6 |
| VTE Prophylaxis With Aspirin 81mg BID | 2 |
Includes a greater than 2g/dL drop in hemoglobin, blood transfusion, hematoma evacuation, re-operation for a deep surgical site infection or minor procedure for bleeding and GI bleed (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 52 |
| VTE Prophylaxis With Aspirin 81mg BID | 53 |
Number of participant received allogenic blood transfusions. (NCT02684851)
Timeframe: post-operative
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic | 21 |
| Placebo | 13 |
To measure average estimate perioperative blood loss (NCT02684851)
Timeframe: perioperative
| Intervention | mL (Mean) |
|---|---|
| Tranexamic | 727.6 |
| Placebo | 560.1 |
Do patients undergoing acetabular ORIF who receive tranexamic acid have a higher risk for thromboembolic events than patients who receive placebo? (NCT02684851)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic | 1 |
| Placebo | 0 |
Average units packed red blood cells transfused among participants (NCT02684851)
Timeframe: perioperative
| Intervention | Units of packed red blood cells (Mean) |
|---|---|
| Tranexamic | 2.65 |
| Placebo | 2.36 |
Changes in Heme oxygenase (HO-1) a downstream target of nitric oxide (NO) formation. (NCT00272311)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| Arm 1 of 5 Randomized Treatment Arms | 27.6 |
| Arm 2 of 5 Randomized Treatment Arms | 27.0 |
| Arm 3 of 5 Randomized Treatment Arms | 31.4 |
| Arm 4 of 5 Randomized Treatment Arms | 25.7 |
| Arm 5 of 5 Randomized Treatment Arms | 28.3 |
"Measure description mg/L refers to the change in hs-CRP per mg/L from the baseline to the follow-up visit. The follow-up visit occurred between 30 and 60 days post baseline." (NCT02666508)
Timeframe: Baseline to 30 - 60 days post baseline
| Intervention | log(mg/L) (Geometric Mean) |
|---|---|
| Plaque Identifying Toothpaste | 0.04 |
| Non-plaque Identifying Toothpaste | 0.22 |
"Measure description mg/L refers to the change in hs-CRP per mg/L from the baseline to the follow-up visit. The follow-up visit occurred between 30 and 60 days post baseline. -PSS analysis" (NCT02666508)
Timeframe: Baseline to 30-60 days post
| Intervention | log(mg/L) (Geometric Mean) |
|---|---|
| Plaque Identifying Toothpaste | -0.40 |
| Non-plaque Identifying Toothpaste | 0.14 |
"Measure description percentage refers to the change in plaque percentage from the baseline to the follow-up visit. The follow-up visit occurred between 30 and 60 days post baseline." (NCT02666508)
Timeframe: Baseline to 30 - 60 days post baseline
| Intervention | log(percentage) (Geometric Mean) |
|---|---|
| Plaque Identifying Toothpaste | -1.05 |
| Non-plaque Identifying Toothpaste | -0.03 |
"Measure description percentage refers to the change in plaque percentage from the baseline to the follow-up visit. The follow-up visit occurred between 30 and 60 days post baseline for the Pre-Specified Subgroup (PSS)." (NCT02666508)
Timeframe: Baseline to 30-60 days post
| Intervention | log(percentage) (Geometric Mean) |
|---|---|
| Plaque Identifying Toothpaste | -1.05 |
| Non-plaque Identifying Toothpaste | -0.10 |
Heme oxygenase a downstream target of nitric oxide formation (NCT00272337)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| 1 of 5 Randomized Treatment Arms | 10.0 |
| 2 of 5 Randomized Treatment Arms | 11.2 |
| 3 of 5 Randomized Treatment Arms | 10.0 |
| 4 of 5 Randomized Treatment Arms | 11.0 |
| 5 of 5 Randomized Treatment Arms | 9.6 |
58 reviews available for aspirin and Thrombophlebitis
| Article | Year |
|---|---|
State of the art--a journey through the world of antithrombotic therapy.
Topics: Ambulatory Care; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Coronary Disease; Fibrinolytic A | 2002 |
Prevention of thrombosis during pregnancy.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Coagulation Tests; B | 2002 |
[Antiphospholipid syndrome].
Topics: Adult; Aged; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Femal | 2002 |
[Traveler's thrombosis].
Topics: Adult; Age Factors; Aged; Aircraft; Anticoagulants; Aspirin; Case-Control Studies; Clinical Trials a | 2003 |
[Method for preventing postoperative thrombophlebitis].
Topics: Aerosols; Anticoagulants; Aspirin; Dextrans; Dipyridamole; Heparin; Humans; Injections, Subcutaneous | 1984 |
Venous thrombosis and embolism.
Topics: Angiography; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Auscultation; Blood Coagulation; Blo | 1981 |
[Pulmonary embolism in surgical patients (author's transl)].
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Bed Rest; Dextrans; Female; Heart Failure; Humans; Intes | 1980 |
Prevention of venous thromboembolism.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Dextrans; Dihydroergotamine; Dipyridamo | 1981 |
Chemistry, measurement, and clinical significance of platelet specific proteins.
Topics: Aspirin; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation; Blood Coagulation Factors; Blood P | 1982 |
Prophylaxis of postoperative deep vein thrombosis and pulmonary embolism.
Topics: Adult; Age Factors; Anticoagulants; Aspirin; Clothing; Dextrans; Early Ambulation; Heparin; Hip Join | 1983 |
Eicosanoids and venous thromboembolism.
Topics: Animals; Arachidonic Acids; Aspirin; Dipyridamole; Dogs; Epoprostenol; Hemostasis; Humans; Platelet | 1983 |
[Current clinical results of antiplatelet medication].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Dipyridamole; D | 1984 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprof | 1980 |
Low-dose heparin: an aid to therapy.
Topics: Aspirin; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Electric Stimulation; Hem | 1980 |
Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Dipyridamole; Sulfinpyrazone; T | 1980 |
Potential and problems with the clinical use of heparin.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Synergism; Fibrinolytic Agents; Hepa | 1980 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Hea | 1981 |
Cerebrovascular disease.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Platelets; Cerebrovascular Disorders; Fibrin | 1981 |
[Prophylaxis of deep vein thrombosis in orthopedic surgery. Discussion and review of the literature].
Topics: 4-Hydroxycoumarins; Anticoagulants; Aspirin; Dextrans; Heparin; Hip Prosthesis; Humans; Indenes; Kne | 1994 |
Oral anticoagulant treatment with and without aspirin.
Topics: Administration, Oral; Angina, Unstable; Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridam | 1995 |
Advances in antithrombotic therapy: novel agents.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Antithrombins; Aspirin; Clinical Trials as Topic; | 1995 |
Antiplatelet therapy and the prevention of thrombosis.
Topics: Aspirin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trial | 1996 |
The cost and benefit of prophylaxis against deep vein thrombosis in elective hip replacement. DVT/PE Prophylaxis Consensus Forum.
Topics: Anticoagulants; Aspirin; Bandages; Clinical Protocols; Cost-Benefit Analysis; Decision Trees; Emboli | 1997 |
Triflusal.
Topics: Adult; Angina Pectoris; Animals; Aspirin; Carotid Stenosis; Humans; In Vitro Techniques; Middle Aged | 1998 |
[Indications and uncertainties of antiaggregating agents].
Topics: Anticoagulants; Aspirin; Clofibrate; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregati | 1977 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coro | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; | 1978 |
New developments in the detection and prevention of venous thromboembolism.
Topics: Aspirin; Clothing; Dextrans; Electric Stimulation Therapy; Fibrinolytic Agents; Heparin; Hip Joint; | 1979 |
Antiplatelet drugs in thromboembolism.
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Drug Therapy, Combination; | 1979 |
[Prevention of thrombosis and embolism in digestive surgery].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Digestive System Surgical Procedures; Dipyridamole; He | 1979 |
Prophylaxis of thromboembolism.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dextrans; Electric Stimulation Therapy; Equipment and | 1979 |
[Anticoagulation therapy in myocardial infarction (author's transl)].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Fibrinolysis; Heparin; Humans; Leg; Myocardial Inf | 1975 |
[Current trends in anticoagulant and thrombolytic therapy of thrombosis].
Topics: Anticoagulants; Aspergillus; Aspirin; Brinolase; Coumarins; Dipyridamole; Disseminated Intravascular | 1975 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibr | 1976 |
Are agents affecting platelet functions clinically useful?
Topics: Aged; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyrida | 1976 |
Deep vein thrombosis. Detection and prevention.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dextrans; Dipyridamole; Female; Fibrinogen; Heparin; | 1975 |
Low dose heparin in the prevention of venous thromboembolism. Rationale and results.
Topics: Acenocoumarol; Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Heparin; Hip; Human | 1975 |
The prevention of postoperative deep vein thrombosis.
Topics: Adult; Aspirin; Atmospheric Pressure; Clinical Trials as Topic; Dextrans; Electric Stimulation; Ethy | 1975 |
Prevention of venous thromboembolism.
Topics: Anticoagulants; Aspirin; Bandages; Cerebrovascular Disorders; Gravity Suits; Humans; Myocardial Infa | 1992 |
Use of antithrombotic agents during pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fetal Diseases; Hemorrhage; Humans; Oste | 1992 |
[Pulmonary thromboembolism].
Topics: Aspirin; Dextrans; Drug Evaluation; Fibrinolytic Agents; Heparin; Humans; Postoperative Complication | 1991 |
Deep venous thrombosis and pulmonary emboli: etiology, medical treatment, and prophylaxis.
Topics: Ancrod; Aspirin; Dextrans; Fibrinolytic Agents; Heparin; Humans; Pulmonary Embolism; Risk Factors; T | 1989 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
Effectiveness of anticoagulants.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood | 1986 |
[Anti-aggregating agents: for which patients?].
Topics: Angina, Unstable; Aspirin; Coronary Artery Bypass; Heart Valve Prosthesis; Humans; Myocardial Infarc | 1986 |
Aspirin and other platelet-aggregation inhibiting drugs.
Topics: Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Female; Heart Valv | 1985 |
Diagnosis and management of thromboembolic disease during pregnancy.
Topics: Acute Disease; Aspirin; Bacterial Infections; Female; Heparin; Humans; Ovary; Phlebography; Plethysm | 1985 |
Trends in the development of antithrombotic agents.
Topics: Adenine Nucleotides; Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Anticoagulants; As | 1971 |
Prevention of thromboembolism after hip fracture.
Topics: Aged; Anticoagulants; Aspirin; Bandages; Coumarins; Dextrans; Exercise Therapy; Femoral Neck Fractur | 1973 |
Prevention and management of venous thrombosis and pulmonary embolism.
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Dipyridamole; Female; Heparin; Humans; Male; Methods; | 1973 |
The mechanisms of venous thrombosis. Anticoagulants, aspirin, and heparin.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Heparin; Humans; In | 1973 |
Deep venous thrombosis. II. Management.
Topics: Anticoagulants; Aspirin; Dextrans; Heparin; Humans; Postoperative Complications; Pulmonary Embolism; | 1973 |
Thromboembolism. Diagnosis and treatment.
Topics: Adult; Aspirin; Dipyridamole; Femoral Vein; Fibrinogen; Heparin; Humans; Iliac Vein; Iodine Radioiso | 1974 |
[Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
Topics: Adult; Aspirin; Blood Platelets; Child; Clofibrate; Dextrans; Dipyridamole; Drug Combinations; Graft | 1974 |
[New possibilities for the prophylaxis of postoperative acute deep thrombophlebitis].
Topics: Administration, Oral; Anticoagulants; Ascorbic Acid; Aspirin; Dextrans; Ethylestrenol; Fibrinogen; H | 1974 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamol | 1974 |
Anticoagulants.
Topics: Anticoagulants; Aspirin; Blood Platelet Disorders; Dipyridamole; Enzyme Therapy; Factor IX; Factor V | 1974 |
The diagnosis and prevention of post operative venous thrombosis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Depression, Chemical; Dextrans; Fibr | 1973 |
64 trials available for aspirin and Thrombophlebitis
| Article | Year |
|---|---|
A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Topics: Adrenergic beta-Antagonists; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascula | 1980 |
Venous thrombosis and embolism.
Topics: Angiography; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Auscultation; Blood Coagulation; Blo | 1981 |
Thromboembolism after hip surgery.
Topics: Aspirin; Clinical Trials as Topic; Dextrans; Dihydroergotamine; Dipyridamole; Drug Therapy, Combinat | 1981 |
Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fema | 1983 |
Prophylaxis of venous thromboembolism by aspirin, warfarin and heparin in patients with hip fracture. A prospective clinical study with cost-benefit analysis.
Topics: Adult; Aspirin; Cost-Benefit Analysis; Female; Heparin; Hip Fractures; Humans; Male; Prospective Stu | 1984 |
Registry of prospective clinical trials--fifth report.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Bl | 1982 |
Deep vein thrombosis in spinal cord injury: effect of prophylaxis with calf compression, aspirin, and dipyridamole.
Topics: Aspirin; Dipyridamole; Factor VIII; Humans; Leg; Platelet Aggregation; Pressure; Prospective Studies | 1982 |
Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression.
Topics: Adult; Age Factors; Aged; Aspirin; Blood Coagulation Tests; Clinical Trials as Topic; Drug Administr | 1980 |
Low-dose heparin: an aid to therapy.
Topics: Aspirin; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Electric Stimulation; Hem | 1980 |
[Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Throm | 1982 |
Platelet count, antiplatelet therapy and pulmonary embolism--a prospective study in patients with hip surgery.
Topics: Aged; Aged, 80 and over; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage | 1995 |
The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Epidural; Aspirin; Blood Loss, Surgical; Female; Gravity | 1994 |
Thromboembolism after THR: prophylaxis and treatment.
Topics: Adult; Aged; Anesthesia, Epidural; Anesthesia, General; Aspirin; Bandages; Blood Loss, Surgical; Fem | 1995 |
Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone.
Topics: Arthritis, Rheumatoid; Aspirin; Bandages; Combined Modality Therapy; Female; Foot; Humans; Joint Pro | 1996 |
The frequency of venous thrombosis in cemented and non-cemented hip arthroplasty.
Topics: Aged; Anticoagulants; Aspirin; Female; Hip Prosthesis; Humans; Male; Middle Aged; Ontario; Phlebogra | 1996 |
Randomized trial of epidural versus general anesthesia: outcomes after primary total knee replacement.
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Aspirin; Female; Humans; Knee Prosthesis; Male; Mid | 1996 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; C- | 1997 |
Deep vein thrombosis after uncemented total hip replacement.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Bone Cement | 1997 |
Place of aspirin in prophylaxis of venous thromboembolism.
Topics: Arthroplasty, Replacement, Hip; Aspirin; Dose-Response Relationship, Drug; Hip Fractures; Humans; Pl | 2000 |
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Aspirin; Cause of Death; Dose-Response Rela | 2000 |
Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trials.
Topics: Ancrod; Animals; Arterial Occlusive Diseases; Aspirin; Batroxobin; Clinical Trials as Topic; Fibrino | 1975 |
Prevention of postoperative thrombosis by aspirin.
Topics: Aspirin; Clinical Trials as Topic; Drug Evaluation; Hip Joint; Humans; Hydroxychloroquine; Joint Pro | 1977 |
Aspirin prophylaxis of venous thromboembolism after total hip replacement.
Topics: Adult; Aspirin; Clinical Trials as Topic; Female; Fibrinogen; Hip Joint; Humans; Joint Prosthesis; M | 1977 |
Aspirin for prophylaxis of venous thromboembolism.
Topics: Aspirin; Clinical Trials as Topic; Female; Humans; Male; Postoperative Complications; Thromboembolis | 1978 |
Drug therapy: antiplatelet therapy (second of two parts).
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical T | 1978 |
Comparision of low dose heparin and low dose heparin combined with aspirin in prevention of deep vein thrombosis after total hip replacement.
Topics: Aspirin; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Joint Pros | 1977 |
Sex, aspirin, and venous thrombosis.
Topics: Aspirin; Clinical Trials as Topic; Double-Blind Method; Female; Hip; Humans; Joint Prosthesis; Leg; | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; | 1978 |
[Optimation of postoperative prophylaxis of thrombosis in gynaecology (author's transl)].
Topics: Adult; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Female; Genital Diseases, Female; Hepa | 1978 |
The hazards of aspirin plus heparin.
Topics: Aspirin; Drug Therapy, Combination; Hemorrhage; Heparin; Hip Fractures; Humans; Thrombophlebitis; Wa | 1978 |
[Heparin in the prevention of thromboembolism after elective hip-joint operations (author's transl)].
Topics: Aspirin; Female; Germany, West; Heparin; Hip Joint; Humans; Male; Middle Aged; Postoperative Complic | 1978 |
Prevention of postoperative deep vein thrombosis with dipyridamole and aspirin.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Middle Aged; Pla | 1976 |
Mechanism of action and clinical use of acetylsalicylic acid as a prophylactic agent against thrombosis.
Topics: Aspirin; Cardiac Surgical Procedures; Clinical Trials as Topic; Humans; Leg; Placebos; Platelet Aggr | 1975 |
Anti-aggregants in clinical practice.
Topics: Arteriosclerosis; Aspirin; Clinical Trials as Topic; Embolism; Humans; Platelet Aggregation; Thrombo | 1975 |
Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin, and flurbiprofen.
Topics: Age Factors; Aged; Aspirin; Dipyridamole; Drug Evaluation; Femoral Neck Fractures; Flurbiprofen; Hep | 1977 |
[Low-dose heparin and acetyl-salicylic acid after elective operations on the hip joint (author's transl)].
Topics: Aged; Aspirin; Female; Heparin; Hip Joint; Humans; Joint Prosthesis; Male; Middle Aged; Postoperativ | 1977 |
[Quantitative assessment of drug-induced prophylaxis of postoperative thromboembolism. Comparison of frequencies of deep vein thrombosis and pulmonary embolism using acetylsalicylic-acid, dextran, dihydroergotamine, low-dose heparin and the fixed combinat
Topics: Adult; Aged; Aspirin; Dextrans; Dihydroergotamine; Drug Therapy, Combination; Female; Heparin; Human | 1977 |
[Thrombosis, embolism and aggregation inhibitors in surgery].
Topics: Aged; Anticoagulants; Aspirin; Dipyridamole; Female; Humans; Male; Platelet Aggregation; Postoperati | 1976 |
Low dose heparin in the prevention of venous thromboembolism. Rationale and results.
Topics: Acenocoumarol; Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Heparin; Hip; Human | 1975 |
The prevention of postoperative deep vein thrombosis.
Topics: Adult; Aspirin; Atmospheric Pressure; Clinical Trials as Topic; Dextrans; Electric Stimulation; Ethy | 1975 |
The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Collagen; Dipyri | 1975 |
Acetylsalicylic acid in a trial to diminish thromboembolic complications after elective hip surgery.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Female; Hip; Humans; Male; Middle Aged; Osteoarthrit | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrin | 1975 |
Proceedings: Failure of aspirin and dipyridamole to influence the incidence of leg scan detected venous thrombosis after elective hip surgery.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Hip; Humans; Leg; Postoperative Complications; Thro | 1975 |
The influence of aspirin on postoperative platelet kinetics and venous thrombosis.
Topics: Adult; Aged; Aspirin; Blood Cell Count; Blood Platelets; Cell Survival; Chromium Radioisotopes; Fema | 1975 |
Influence of prophylaxis on proximal venous thrombus formation after total hip arthroplasty.
Topics: Adult; Aspirin; Combined Modality Therapy; Dextrans; Female; Gravity Suits; Hemorrhage; Hip Prosthes | 1992 |
Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin.
Topics: Adult; Age Factors; Aged; Aspirin; Bandages; Combined Modality Therapy; Female; Heparin; Hip Prosthe | 1991 |
Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty.
Topics: Aged; Aspirin; Bandages; Female; Humans; Knee Joint; Knee Prosthesis; Male; Postoperative Complicati | 1990 |
[Prevention of deep venous thrombosis in hip surgery].
Topics: Aged; Aspirin; Dextrans; Dose-Response Relationship, Drug; Early Ambulation; Hemodilution; Heparin; | 1986 |
Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily.
Topics: Aspirin; Clinical Trials as Topic; Dextrans; Female; Hip Prosthesis; Humans; Male; Methods; Postoper | 1985 |
Dextran/aspirin versus heparin/dihydroergotamine in preventing thrombosis after hip fractures.
Topics: Aged; Aspirin; Clinical Trials as Topic; Dextrans; Dihydroergotamine; Double-Blind Method; Drug Ther | 1985 |
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clinical Trials as Topic; Female; Follow-Up Studies; Hemorr | 1989 |
Prevention of deep venous thrombosis in orthopedic surgery: effects of defibrotide.
Topics: Aged; Aspirin; Female; Fibrinolytic Agents; Heparin; Hip Joint; Humans; Male; Orthopedics; Polydeoxy | 1988 |
Effectiveness of anticoagulants.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood | 1986 |
Effect of aspirin on postoperative venous thrombosis. Report of the Steering Committee of a trial sponsored by the Medical Research Council.
Topics: Adult; Age Factors; Aspirin; Blood Group Antigens; Blood Platelets; Clinical Trials as Topic; Female | 1972 |
Aspirin and postoperative venous thrombosis.
Topics: Aspirin; Clinical Trials as Topic; Humans; Postoperative Complications; Thrombophlebitis | 1972 |
[Clinical results of systemic and the new local administration form of Bayro Vas].
Topics: Adult; Aged; Aspirin; Drug Combinations; Ethanolamines; Female; Gels; Humans; Male; Middle Aged; Pla | 1973 |
[Thromboembolic complications following total hip prosthesis. Study of 478 cases of relative efficacy of 3 preventive methods].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Drug Evaluation; Drug Therapy, Combinat | 1974 |
Review of present status of prophylaxis of venous thromboembolism.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Fibrinolysis; Heparin; Humans; Phy | 1974 |
Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis.
Topics: Aspirin; Dipyridamole; Femoral Neck Fractures; Fibrinogen; Humans; Iodine Radioisotopes; Placebos; P | 1973 |
[Prevention of postoperative thrombo-embolism with acetylsalicyclic acid (author's transl)].
Topics: Age Factors; Angina Pectoris; Aspirin; Body Weight; Diabetes Complications; Female; Follow-Up Studie | 1974 |
Oral bromelains as adjuncts in the treatment of acute thrombophlebitis.
Topics: Acute Disease; Adult; Aged; Aspirin; Bromelains; Clinical Trials as Topic; Codeine; Female; Humans; | 1969 |
Prevention of postoperative venous thrombosis.
Topics: Aspirin; Clinical Trials as Topic; Heparin; Hip; Humans; Postoperative Complications; Thromboembolis | 1971 |
Reduction in venous thromboembolism by agents affecting platelet function.
Topics: Adult; Aged; Arthroplasty; Aspirin; Blood Platelets; Chromium Alloys; Dextrans; Dipyridamole; Female | 1971 |
152 other studies available for aspirin and Thrombophlebitis
| Article | Year |
|---|---|
Aspirin may prevent blood clots in the legs from recurring.
Topics: Anticoagulants; Aspirin; Humans; Secondary Prevention; Thrombophlebitis | 2013 |
Recurrent thromboembolism in a patient with beta-thalassemia major associated with double heterozygosity for factor V R506Q and prothrombin G20210A mutations.
Topics: 3' Untranslated Regions; Activated Protein C Resistance; Adult; Anticoagulants; Aspirin; beta-Thalas | 2002 |
[Mondor's thrombophlebitis and antiphospholipid antibodies].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndr | 2003 |
["How must deep leg venous thrombosis be diagnosed and treated?"].
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Blood Coagulation Tests; Blood Viscosity; F | 2003 |
[Prevention of postoperative thrombosis of the deep veins of the lower limbs].
Topics: Aspirin; Clothing; Dextrans; Dihydroergotamine; Early Ambulation; Heparin; Humans; Postoperative Com | 1984 |
Aspirin inhibition of thromboxane release in thrombosis and renal transplant rejection.
Topics: Aspirin; Graft Rejection; Humans; Kidney Transplantation; Thrombophlebitis; Thromboxane B2; Thrombox | 1982 |
Fetal survival after prednisone suppression of maternal lupus-anticoagulant.
Topics: Adult; Antibodies, Antinuclear; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Fem | 1983 |
Postoperative venous thrombosis. Evaluation of five methods of treatment.
Topics: Adult; Age Factors; Aged; Aspirin; Clothing; Dextrans; Female; Fibrinogen; Heparin; Humans; Iodine R | 1981 |
Experience with deep venous thrombosis and IPG - 200 as a diagnostic aid.
Topics: Adult; Aged; Aspirin; Dextrans; Diagnosis, Differential; Female; Heparin; Humans; Male; Middle Aged; | 1980 |
[Prevention of deep vein thrombosis and pulmonary thromboembolism].
Topics: Anticoagulants; Aspirin; Constriction; Dextrans; Electric Stimulation Therapy; Heparin; Humans; Phys | 1981 |
Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities.
Topics: Adult; Aged; Aspirin; Clothing; Combined Modality Therapy; Dextrans; Heparin; Humans; Middle Aged; M | 1983 |
[Preoperative hemodilution as prophylaxis of deep vein thrombosis].
Topics: Adult; Aged; Aspirin; Dextrans; Fibrinogen; Hemodilution; Humans; Middle Aged; Phlebography; Preoper | 1984 |
In vivo platelet activation in lower limbs thrombophlebitis. A longitudinal study.
Topics: Adult; Aspirin; beta-Thromboglobulin; Blood Platelets; Dipyridamole; Female; Heparin; Humans; Longit | 1984 |
Aspirin as an antithrombotic medication.
Topics: Arachidonic Acids; Aspirin; Epoprostenol; Humans; Platelet Aggregation; Postoperative Complications; | 1983 |
Lupus anticoagulant in pregnancy.
Topics: Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Drug Therapy, Combination; | 1984 |
Drugs in the treatment of thrombo-embolic disease--part I.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovasc | 1983 |
Urinary excretion of thromboxane B2 in patients with venous thromboembolic disease.
Topics: Angiography; Aspirin; Humans; Lung; Platelet Function Tests; Pulmonary Embolism; Radioimmunoassay; T | 1984 |
[Treatment of thrombotic occlusion of the pelvic and extremity veins. Comparison of three different types of treatment].
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Heparin; Humans; Male; Pelvis; Postoperative Comp | 1984 |
Prophylaxis of venous thromboembolism: analysis of cost effectiveness.
Topics: Aspirin; Cost-Benefit Analysis; Dextrans; Heparin; Humans; Injections, Subcutaneous; Pulmonary Embol | 1980 |
Antiplatelet therapy.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprost | 1981 |
Effect of platelet aggregation inhibitors on the rate of thrombectomy following arterial reconstructions with Gore-Tex prostheses: a retrospective study.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Humans; Ischemia; Leg; Platelet Aggregation; Postope | 1982 |
Case study: complications associated with anticoagulant therapy.
Topics: Adult; Anticoagulants; Aspirin; Drug Interactions; Hemorrhage; Heparin; Humans; Male; Thrombophlebit | 1981 |
[Aspirin sensitivity of healthy persons and patients].
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Coronary Disease; Drug Resistance; Female; Humans; Male; Mid | 1981 |
Current concepts review. The use of aspirin in thromboembolic disease.
Topics: Adult; Aspirin; Female; Hip Prosthesis; Humans; Male; Platelet Aggregation; Postoperative Complicati | 1980 |
Failure of aspirin at different doses to modify experimental thrombosis in rats.
Topics: Animals; Aorta, Abdominal; Aspirin; Dose-Response Relationship, Drug; Male; Prostaglandins; Rats; Th | 1980 |
Triple therapy for acute deep thrombophlebitis.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Chymotrypsin; Drug Th | 1980 |
Management of venous thromboembolism.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Fibrinolytic Agents; Heparin; Humans; Isometric | 1980 |
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Human | 1980 |
Effect of anticoagulation and inhibition of platelet aggregation on arterial versus venous microvascular thrombosis.
Topics: Animals; Aspirin; Blood Coagulation; Dipyridamole; Femoral Artery; Femoral Vein; Fibrinolytic Agents | 1995 |
[Current aspects of postoperative thrombophlebitis and pulmonary artery thromboembolism].
Topics: Adult; Age Factors; Aspirin; Bandages; Dextrans; Heparin; Humans; Iodine Radioisotopes; Middle Aged; | 1994 |
[23-year-old patient with abdominal pain, hepatosplenomegaly, ascites and leg edema].
Topics: Adult; Ascites; Aspirin; Biopsy; Blood Coagulation Tests; Budd-Chiari Syndrome; Combined Modality Th | 1995 |
Clinical efficacy of aspirin and dextran for thromboprophylaxis in geriatric hip fracture patients.
Topics: Aged; Aspirin; Dextrans; Female; Hip Fractures; Humans; Male; Prospective Studies; Pulmonary Embolis | 1993 |
Synergistic antiplatelet effects of a nipecotamide A-1C and low dose aspirin.
Topics: Adult; Animals; Aspirin; Collagen; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Fe | 1994 |
Routine postoperative duplex ultrasonography screening and monitoring for the detection of deep vein thrombosis. A survey of 110 total hip arthroplasties.
Topics: Anticoagulants; Aspirin; Cohort Studies; Female; Gravity Suits; Hip Prosthesis; Humans; Male; Phlebo | 1994 |
A new animal model of venous thrombosis in rats with low flow conditions in the venous blood stream.
Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Constriction; Disease Models, Animal; Epopros | 1994 |
Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: importance of PAF.
Topics: Animals; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Doxorubicin; Leukocyte Count; Male; | 1994 |
Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons.
Topics: Arthroplasty; Aspirin; Femoral Neck Fractures; Heparin; Heparin, Low-Molecular-Weight; Hip Joint; Hu | 1994 |
[Simultaneous administration of coumarin derivatives and acetylsalicylic acid?].
Topics: Aspirin; Coumarins; Drug Interactions; Drug Therapy, Combination; Humans; Thrombophlebitis | 1994 |
Oral anticoagulant therapy recommendations.
Topics: Administration, Oral; Aspirin; Clinical Protocols; Hemorrhage; Humans; Thromboembolism; Thrombophleb | 1994 |
[Hereditary spherocytosis].
Topics: Aspirin; Combined Modality Therapy; Erythrocyte Count; Humans; Recurrence; Spherocytosis, Hereditary | 1994 |
Changing patterns of prophylaxis for deep venous thrombosis following elective hip replacement.
Topics: Aspirin; Heparin; Hip Prosthesis; Humans; Medical Audit; Retrospective Studies; Thrombolytic Therapy | 1993 |
Reversible dementia and chorea in a young woman with the lupus anticoagulant.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Chorea; Dementia; Depression; Diagno | 1996 |
[Comprehensive prevention of postoperative thrombosis].
Topics: Anticoagulants; Aspirin; Dextrans; Drug Therapy, Combination; Female; Hemodilution; Heparin; Humans; | 1996 |
Antithrombotic effects of aspirin and LMWH in a laser-induced model of arterials and venous thrombosis.
Topics: Administration, Cutaneous; Animals; Aspirin; Disease Models, Animal; Heparin, Low-Molecular-Weight; | 1996 |
Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.
Topics: Animals; Antithrombins; Arginine; Aspirin; Bleeding Time; Disease Models, Animal; Fibrinolytic Agent | 1996 |
Predictors of mortality after acute hip fracture.
Topics: Aged; Aged, 80 and over; Aspirin; Comorbidity; Female; Hip Fractures; Hospital Mortality; Humans; Io | 1996 |
Thromboprophylaxis in elective orthopaedic surgery -- what is the purpose?
Topics: Anticoagulants; Aspirin; Bone and Bones; Chemoprevention; Elective Surgical Procedures; Femoral Neck | 1997 |
Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 1998 |
Deep-vein thrombosis in long-haul flights.
Topics: Anticoagulants; Aspirin; Bandages; Heparin, Low-Molecular-Weight; Humans; Thrombophlebitis; Travel; | 2001 |
Fibrinogen catabolism in the surgically treated patient and in those with postoperative venous thrombosis. Correlation of plasma fibrinogen chromatographic findings with 125I-labeled fibrinogen scan findings.
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Aspirin; Chromato | 1977 |
[Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Topics: Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Humans; Ischemic Attack, Transient; Myocard | 1979 |
Aspirin prophylaxis of venous thromboembolic disease following fracture of the upper femur.
Topics: Aged; Aspirin; Female; Femoral Neck Fractures; Hip Fractures; Hip Prosthesis; Humans; Male; Middle A | 1979 |
Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery.
Topics: Adult; Aged; Aspirin; Elasticity; Female; Humans; Knee; Leg; Male; Middle Aged; Phlebography; Pulmon | 1979 |
'Spontaneous' platelet aggregation: its characteristics and relation to aggregation by other agents.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cell Count; Cerebrovascular Disorders; Female; Humans; Ischem | 1978 |
[Prevention of thromboembolism with antiaggregants (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Cats; Dipyridamole; Dogs; Drug Synergism; Heparin; Platelet Aggreg | 1977 |
[Experimental venous thrombosis in guinea pigs: effect of heparin and drugs affecting platelet function (author's transl)].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Blood Platelets; Dextrans; Dipyridamole; | 1977 |
Aspirin in the prophylaxis of venous and arterial diseases.
Topics: Arterial Occlusive Diseases; Aspirin; Humans; Platelet Adhesiveness; Platelet Aggregation; Thromboph | 1977 |
Failure of aspirin to prevent postoperative deep vein thrombosis in patients undergoing total hip replacement.
Topics: Aged; Aspirin; Female; Hip Joint; Humans; Male; Middle Aged; Postoperative Complications; Thrombophl | 1978 |
Modified "low-dose" heparin prophylaxis to reduce thrombosis after hip joint operations.
Topics: Adult; Aged; Aspirin; Evaluation Studies as Topic; Female; Hematoma; Heparin; Hip Joint; Humans; Leg | 1978 |
[Deep-vein thrombosis after hip replacement].
Topics: Aspirin; Hip Joint; Humans; Postoperative Complications; Thrombophlebitis | 1978 |
[Observations and results of photodocumentation of retinal thromboses treated with Colfarit (author's transl)].
Topics: Aspirin; Fibrinolytic Agents; Follow-Up Studies; Fundus Oculi; Humans; Photography; Retinal Diseases | 1978 |
[Clinical and in-vitro studies of the therapeutical range of acetylsalicylic-acid to prevent deep vein thrombosis (author's transl)].
Topics: Aged; Aspirin; Hip Joint; Humans; Male; Middle Aged; Platelet Aggregation; Postoperative Complicatio | 1978 |
[Early diagnosis of postoperative venous thrombosis and evaluation of the effects of pharmacological prevention of thrombosis].
Topics: Aspirin; Dipyridamole; Heparin; Humans; Postoperative Complications; Thrombophlebitis | 1978 |
Effects of aspirin and dextran on patency of bovine heterografts in the venous system.
Topics: Administration, Oral; Animals; Aspirin; Cattle; Dextrans; Dogs; Drug Evaluation, Preclinical; Female | 1979 |
Antithrombotic therapy. Rationale and application.
Topics: Anticoagulants; Arteries; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Coagulation Factors; D | 1979 |
Antiplatelet and antithrombogenic effects of suloctidil.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Pressure; Dogs; Female; Fibrinolytic Agents; Haplorhi | 1976 |
A multifaceted approach to prevention of thromboembolism: a report of 529 cases.
Topics: Aspirin; Bandages; Dextrans; Exercise Therapy; Heparin; Hip Joint; Humans; Joint Prosthesis; Phenylb | 1977 |
A ten year study of heparin therapy for thrombophlebitis in ambulatory patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Ambulatory Care; Aspirin; Blood Coagulation Tests; Chronic D | 1977 |
The prevention of acute pulmonary embolism.
Topics: Adult; Anticoagulants; Aspirin; Dextrans; Early Ambulation; Female; Heparin; Humans; Leg; Postoperat | 1977 |
The present status of acute deep venous thrombosis.
Topics: Acute Disease; Aspirin; Dextrans; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Plethysmography | 1977 |
Aspirin and thromboembolism--a possible dilemma.
Topics: Aspirin; Blood Platelets; Female; Hip Joint; Humans; Male; Prostaglandins; Sex Factors; Thromboembol | 1977 |
Platelets, aspirin and cardiovascular disease.
Topics: Aspirin; Cardiovascular Diseases; Humans; Myocardial Infarction; Platelet Aggregation; Thromboemboli | 1976 |
Thromboembolism following total hip-replacement arthroplasty. The efficicy of dextran-aspirin and dextran-warfarin in prophylaxis.
Topics: Arthroplasty; Aspirin; Dextrans; Drug Therapy, Combination; Female; Hip Joint; Humans; Joint Prosthe | 1976 |
A clinical evaluation of aspirin prophylaxis of thromboembolic disease after total hip arthroplasty.
Topics: Adolescent; Adult; Aged; Arthroplasty; Aspirin; Female; Hip Joint; Humans; Joint Prosthesis; Male; M | 1976 |
Thromboembolic disease in patients undergoing total knee replacement.
Topics: Aged; Aspirin; Fibrinogen; Humans; Joint Prosthesis; Knee Joint; Middle Aged; Phlebography; Postoper | 1976 |
[Role of drugs with disaggregative effect in the prevention of thrombosis in reconstructive operations on the veins of the limbs].
Topics: Aspirin; Humans; Leg; Platelet Aggregation; Postoperative Complications; Thrombophlebitis; Varicose | 1976 |
[A comparative investigation of acetylsalicyclic acid and indirect anticoagulants for the prophylaxis of venous thromboses in patients with an orthopedic-traumatologic case history (author's transl)].
Topics: Aspirin; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteotomy; Phenindione; Postoperative C | 1976 |
Combined administration of low dose heparin and aspirin as prophylaxis of deep vein thrombosis after hip joint surgery.
Topics: Adult; Aged; Aspirin; Drug Therapy, Combination; Female; Heparin; Hip Joint; Humans; Male; Middle Ag | 1976 |
[Inhibition of aggregation in the prevention of venous thromboses (proceedings)].
Topics: Aspirin; Humans; Platelet Aggregation; Postoperative Complications; Thrombophlebitis | 1976 |
[The thrombosis of superficial venous system].
Topics: Aged; Aspirin; Coumarins; Female; Humans; Male; Microcirculation; Middle Aged; Necrosis; Phlebograph | 1975 |
Prophylaxis of venous thromboembolism.
Topics: Aspirin; Blood Coagulation; Dextrans; Dipyridamole; Ethylestrenol; Fibrinolysis; Heparin; Humans; Ph | 1975 |
Platelet kinetics--1975.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Extracorporeal Circulation; Heart Valve | 1975 |
Platelet hyperaggregability in idiopathic recurrent deep vein thrombosis.
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Male; Methods; Middle Aged; Platelet | 1976 |
Individual and combined effects of a thromboxane receptor antagonist and different antithrombotic agents in a rat microcirculatory thrombosis model.
Topics: Animals; Aspirin; Drug Synergism; Epoprostenol; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; | 1992 |
Venous thromboembolism associated with hip and knee arthroplasty: current prophylactic practices and outcomes.
Topics: Aspirin; Bandages; Hip Prosthesis; Humans; Knee Prosthesis; Postoperative Complications; Pulmonary E | 1992 |
[Prevention of thrombosis after surgical interventions on the venous system].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combin | 1992 |
Atypical thrombotic and septic complications of totally implantable venous access devices in patients with cystic fibrosis.
Topics: Adolescent; Adult; Aspirin; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Pr | 1992 |
Multiple complications of the antiphospholipid syndrome with apparent response to aspirin therapy.
Topics: Adult; Anemia, Hemolytic; Antiphospholipid Syndrome; Aspirin; Cyclophosphamide; Dose-Response Relati | 1992 |
[Heparin-associated thrombocytopenia, thrombosis and embolism. Side effects of thromboembolism prevention with low molecular weight heparin enoxaparin?].
Topics: Aged; Aspirin; Blood Coagulation Tests; Carcinoma, Renal Cell; Heparin, Low-Molecular-Weight; Humans | 1991 |
Requirement of heparin for arterial and venous thrombolysis with recombinant tissue-type plasminogen activator.
Topics: Animals; Aspirin; Dogs; Heparin; Recombinant Proteins; Thrombophlebitis; Thrombosis; Tissue Plasmino | 1991 |
Effect of aspirin on heterotopic ossification after total hip arthroplasty in men who have osteoarthrosis.
Topics: Aged; Aged, 80 and over; Aspirin; Hip Prosthesis; Humans; Length of Stay; Male; Middle Aged; Ossific | 1991 |
Air travel, DVTs and pulmonary embolism.
Topics: Aircraft; Aspirin; Humans; Pulmonary Embolism; Thrombophlebitis; Travel | 1991 |
Air travel, DVTs and pulmonary embolism.
Topics: Aircraft; Aspirin; Humans; Pulmonary Embolism; Thrombophlebitis; Travel | 1991 |
Aspirin prophylaxis and surveillance of pulmonary embolism and deep vein thrombosis in total hip arthroplasty.
Topics: Aspirin; Female; Hip Prosthesis; Humans; Lung; Male; Middle Aged; Postoperative Complications; Preme | 1990 |
Blue rubber-bleb naevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis.
Topics: Anemia, Hemolytic; Aspirin; Dipyridamole; Disseminated Intravascular Coagulation; Female; Gastrointe | 1990 |
Antithrombotic activity of an unsaturated fatty acid preparation.
Topics: Animals; Aspirin; Drug Interactions; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Fibrin | 1990 |
Prophylaxis of venous thromboembolism. An overview.
Topics: Abdomen; Anticoagulants; Aspirin; Combined Modality Therapy; Cost-Benefit Analysis; Dextrans; Drug T | 1986 |
[Determination of human sensitivity to the antiaggregation action of acetylsalicylic acid].
Topics: Arteriosclerosis; Aspirin; Diabetes Mellitus; Humans; Methods; Myocardial Infarction; Platelet Aggre | 1986 |
Moderate doses of aspirin and risk of bleeding in renal failure.
Topics: Adolescent; Adult; Aged; Aspirin; Bleeding Time; Female; Hemorrhage; Hemostasis; Humans; Infusions, | 1986 |
Aspirin: what dose?
Topics: Aspirin; Coronary Disease; Cyclooxygenase Inhibitors; Fibrinolysis; Humans; Thrombophlebitis | 1986 |
A sensitive model of venous thrombosis in rats.
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Disease Models, Animal; Female; Heparin; Ketanserin; | 1986 |
Antithrombotics in view of thrombosis models.
Topics: Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Female; Hydroxyethylrutoside; Ketanserin; | 1986 |
[Venous diseases of the lower limbs and pulmonary embolism].
Topics: Adult; Aged; Ancrod; Anticoagulants; Aspirin; Female; Humans; Male; Pulmonary Embolism; Thrombophleb | 1988 |
New pharmacologic approaches to thromboembolic disorders.
Topics: Adenylyl Cyclases; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cyclic AMP | 1985 |
Preoperative identification of patients at high risk of deep venous thrombosis despite prophylaxis in total hip replacement.
Topics: Adult; Aspirin; Dihydroergotamine; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Hip Pr | 1988 |
[Mortality and morbidity of thromboembolism in drug prevention--5-year analysis].
Topics: Adenocarcinoma; Adult; Aspirin; Cesarean Section; Dihydroergotamine; Female; Genital Diseases, Femal | 1988 |
A new experimental model of venous thrombosis in rats involving partial stasis and slight endothelium alterations.
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Disease Models, Animal; Endothelium; Male; Micros | 1987 |
Etiology and prevention of thromboembolic disease. Taming a complex circulatory malfunction.
Topics: Antithrombin III Deficiency; Aspirin; Blood Coagulation Disorders; Catheters, Indwelling; Contracept | 1986 |
Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
Topics: alpha-2-Antiplasmin; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Fibrinogen; Glycoprotein | 1985 |
Antithrombotic effect of ticlopidine in a platelet-independent model of venous thrombosis.
Topics: Animals; Aspirin; Blood Platelets; Fibrinolytic Agents; Male; Rats; Rats, Inbred Strains; Thiophenes | 1985 |
[Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Coronary Disease; Extr | 1985 |
Effect of calcium dobesilate and its interaction with aspirin on thrombus formation in vivo.
Topics: Animals; Aspirin; Benzenesulfonates; Calcium Dobesilate; Cricetinae; Drug Evaluation, Preclinical; D | 1985 |
Aspirin against clotting.
Topics: Aspirin; Blood Platelets; Humans; Preoperative Care; Thrombophlebitis; Thrombosis | 1971 |
Aspirin against arterial and venous thrombosis.
Topics: Aspirin; Humans; Thrombophlebitis; Thrombosis | 1971 |
Spontaneous aggregation of blood platelets as a cause of idiopothic thrombosis and recurrent painful toes and fingers.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aspirin; Blood Platelet Disorders; Coumarins; Fingers | 1971 |
Should we stand all day?
Topics: Adult; Aspirin; Blood Coagulation; Blood Vessels; Child; Dextrans; Heparin; Humans; Leg; Plasminogen | 1973 |
Anticoagulants: a guide for practitioners.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Dicumarol; Disseminated Intravascular Coagulation; Electri | 1973 |
Iatrogenic and functional leg pain.
Topics: Aged; Analgesics; Aspirin; Diagnosis, Differential; Diazepam; Fear; Fibromyalgia; Humans; Iatrogenic | 1973 |
The protective effect of acetylsalicylic acid on laser-induced venous thrombosis in the rat.
Topics: Administration, Oral; Animals; Aspirin; Dose-Response Relationship, Drug; Heparin; Jugular Veins; La | 1974 |
Complications revisited. The debit side of total hip replacement.
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Arthroplasty; Aspirin; Bone Cements; Dextrans; Female; | 1973 |
Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.
Topics: Aspirin; Dextrans; Female; Hemorrhage; Heparin; Hip Joint; Humans; Injections, Subcutaneous; Joint P | 1974 |
Ergotamine-induced venous thrombosis.
Topics: Adult; Aspirin; Ergotamine; Female; Humans; Menorrhagia; Thrombophlebitis | 1974 |
Treatment of sickle-cell disease.
Topics: Anemia, Sickle Cell; Anesthesia; Anticoagulants; Aspirin; Bicarbonates; Blood; Blood Flow Velocity; | 1974 |
Influence of simultaneous administration of low-dose heparin and acetylsalicylic acid on blood coagulation and platelet functions.
Topics: Adult; Aged; Aspirin; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; | 1974 |
The experimental evaluation of prophylaxis in venous thrombosis by the use of antiplatelet agents.
Topics: Animals; Aspirin; Blood Coagulation Tests; Dextrans; Dipyridamole; Drug Therapy, Combination; Hepari | 1974 |
Blood transfusion reactions in children.
Topics: Aspirin; Benzyl Compounds; Child; Child, Preschool; Ethylenediamines; Fever; Furosemide; Heart Failu | 1972 |
Clinical and therapeutical problems concerning postthrombotic indurations.
Topics: Ascorbic Acid; Aspirin; Atrophy; Auscultation; Cellulitis; Drug Combinations; Edema; Humans; Leg Ulc | 1972 |
Clinical and experimental findings with acetylsalicylic acid as an inhibitor of platelet aggregation.
Topics: Acetylation; Administration, Oral; Aspirin; Blood Coagulation Tests; Blood Platelets; Carbon Radiois | 1972 |
[Thrombosis prevention using the cava catheter (animal experiments with colfarit)].
Topics: Animals; Aspirin; Catheterization; Rabbits; Thrombophlebitis; Time Factors; Vena Cava, Superior | 1973 |
[Central venous thrombosis and oral contraceptives].
Topics: Aspirin; Contraceptives, Oral; Female; Humans; Middle Aged; Retinal Vein; Thrombophlebitis | 1973 |
[A simple experimental methods ofr quantitative determination of the antithrombogenic effect of blood platelet aggregation inhibitors].
Topics: Animals; Aspirin; Chromium Isotopes; Heparin; Jugular Veins; Methods; Platelet Adhesiveness; Rabbits | 1973 |
The treatment of pulmonary embolism.
Topics: Adult; Aspirin; Blood Coagulation Tests; Cholelithiasis; Diabetes Complications; Female; Heparin; Hu | 1973 |
Impedance phlebography: a correlation with lower limb venography in the diagnosis of deep vein thrombosis.
Topics: Aspirin; Dextrans; False Negative Reactions; False Positive Reactions; Heparin; Hip; Humans; Joint P | 1973 |
[Clinical therapy of leg ulcer and thrombophlebitis using Colfarit].
Topics: Aspirin; Humans; Leg; Leg Ulcer; Thrombophlebitis | 1973 |
[Clinical use of anti-aggregative agents].
Topics: Aspirin; Dipyridamole; Humans; Hydroxychloroquine; Platelet Adhesiveness; Thromboembolism; Thromboph | 1973 |
[Inhibition of experimental thrombosis by combined administration of acetylsalicylic acid and cumarins].
Topics: Animals; Anticoagulants; Aspirin; Benzyl Compounds; Coumarins; Drug Combinations; Female; Jugular Ve | 1973 |
[Prophylaxis and treatment of thromboses of the deep leg veins with acetylsalicylic acid (author's transl)].
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Humans; Leg; Myocardial Infarction; Platelet | 1973 |
[Prophylaxis of thrombo-embolic complications in major surgery of the hip joint. A comparative controlled study with subcutaneous calcium heparinate and acetylsalicylic acid (author's transl)].
Topics: Aspirin; Calcium; Heparin; Hip; Hip Joint; Humans; Injections, Subcutaneous; Joint Prosthesis; Posto | 1973 |
Dipyridamole ("Persantin") and aspirin and the prevention of post-operative deep-vein thrombosis.
Topics: Adult; Aspirin; Dextrans; Dipyridamole; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Huma | 1973 |
Prevention of early vein graft thrombosis by drugs altering platelet function.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dextrans; Dipyridamole; Dogs; Femoral Vein; Iliac Artery; | 1973 |
Postoperative deep vein thrombosis and pulmonary embolism: a selective review and personal viewpoint.
Topics: Adult; Age Factors; Aged; Aspirin; Clothing; Dextrans; Dipyridamole; Exercise Therapy; Heparin; Huma | 1974 |
Inhibition of platelet-induced thrombus formation.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrin | 1974 |
Editorial: Aspirin and atherosclerosis.
Topics: Arteriosclerosis; Aspirin; Depression, Chemical; Humans; Myocardial Infarction; Platelet Adhesivenes | 1974 |
Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Dipyridamole; Drug Synerg | 1974 |
[Aspirin in the treatment of amaurosis. Before or after?].
Topics: Aspirin; Blindness; Dextrans; Humans; Pulmonary Embolism; Thrombophlebitis | 1972 |
[Treatment of thrombophlebitis saltans using acetyl-salicylic acid in microcapsules].
Topics: Adolescent; Adult; Aspirin; Capsules; Female; Humans; Male; Middle Aged; Thrombophlebitis | 1972 |
The effect of acetylsalicylic acid on thrombosis at microvenous anastomotic sites.
Topics: Animals; Aspirin; Collagen; Platelet Adhesiveness; Postoperative Complications; Rabbits; Surgical Wo | 1972 |
[Acetylsalicylic acid in thromboembolic diseases].
Topics: Anticoagulants; Aspirin; Blood Platelets; Humans; Postoperative Complications; Thromboembolism; Thro | 1972 |
Aspirin in venous thrombosis.
Topics: Aspirin; Humans; Platelet Adhesiveness; Thrombophlebitis | 1971 |
[Inhibition of platelet aggregation with acetylsalicylic acid. Experimental and clinical results].
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Blood Platelets; Carbon Isotopes; Drug Synergism; | 1971 |
[Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight].
Topics: Animals; Aspirin; Coronary Disease; Dipyridamole; Humans; Thrombophlebitis; Thrombosis | 1971 |
Thrombosis prevention.
Topics: Animals; Arteries; Arthroplasty; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Hemorrhage; Hip; | 1971 |